ArticleCancer genomics & proteomics

Eribulin Regresses a Doxorubicin-resistant Dedifferentiated Liposarcoma in a Patient-derived Orthotopic Xenograft Mouse Model.

Kentaro Igarashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.